Formulation and Fill/Finish Solutions for Sterile Injectables
From Development to Delivery: Precision and Quality at Every Step
Integrated Fill/Finish Expertise for Injectable Therapies
Afton Scientific offers fill/finish solutions tailored to support a wide range of sterile injectable products. With decades of experience, we streamline the journey from early stages to commercial production, ensuring efficiency, sterility, and regulatory compliance at every stage.
Our capabilities extend across biologics and small molecules as well as emerging modalities, including mRNA therapies, helping our clients bring innovative treatments to market with confidence.
Comprehensive Fill/Finish Solutions
Afton Scientific specializes in precision filling for sterile injectables, ensuring that every product maintains integrity from inception to final delivery.
From clinical supply to full-scale commercial manufacturing, we ensure flexibility, sterility, and consistency in every fill.
Fill/Finish Capabilities including:
Vials
Supporting liquid products with advanced isolator-based filling.
Pre-Filled Syringes
Enhancing ease of use and reducing contamination risks.
Cartridges
Providing solutions for auto-injectors and pen systems.
Scalability and Seamless Process Integration
We simplify technology transfer and scale-up with:
- Streamlined Process Development – Reducing complexity for seamless project execution.
- Flexible Batch Sizes – Supporting clinical trials, commercial supply, and future growth.
- Regulatory and Quality Alignment – Ensuring compliance with FDA, EMA, PMDA, and global standards.
Our collaborative approach ensures that formulation development and filling processes are fully integrated for optimized efficiency and success.
Expanding Capabilities: and Beyond
Expanding Capabilities: Today and Tomorrow
Afton Scientific is continuously investing in advanced aseptic technologies to meet evolving industry needs. Our expansion programs focus on increasing sterile filling capacity and format flexibility for our partners.
• New isolator-based filling line will increase overall throughput while enhancing sterility assurance and contamination control.
• Added capacity for vial filling, supporting both clinical and commercial-scale sterile injectable programs.
• Future-ready capabilities for prefilled syringes (PFS) and cartridges, enabling seamless transitions as products advance through lifecycle stages.